Header Logo

Connection

LAURA MARSH to Humans

Back to Details
This is a "connection" page, showing publications LAURA MARSH has written about Humans.
LAURA MARSH
Connection Strength
0.446
Humans
  1. Physical Violence and Aggression in Parkinson's Disease: A Systematic Review. J Acad Consult Liaison Psychiatry. 2024 Jul-Aug; 65(4):366-378.
    View in: PubMed
    Score: 0.025
  2. Post-Traumatic Stress Disorder and Risk of Degenerative Synucleinopathies: Systematic Review and Meta-Analysis. Am J Geriatr Psychiatry. 2023 11; 31(11):978-990.
    View in: PubMed
    Score: 0.024
  3. Cognitive dysfunction and neuropsychiatric aspects of Parkinson's disease. Prog Brain Res. 2022; 269(1):59-90.
    View in: PubMed
    Score: 0.022
  4. Dream Enactment Behaviors Associated With Posttraumatic Stress Disorder. J Neuropsychiatry Clin Neurosci. 2022; 34(2):124-131.
    View in: PubMed
    Score: 0.021
  5. Models for treating depression in specialty medical settings: a narrative review. Gen Hosp Psychiatry. 2015 Jul-Aug; 37(4):315-22.
    View in: PubMed
    Score: 0.014
  6. Depression and Parkinson's disease: current knowledge. Curr Neurol Neurosci Rep. 2013 Dec; 13(12):409.
    View in: PubMed
    Score: 0.012
  7. Psychiatric comorbidities in dystonia: emerging concepts. Mov Disord. 2013 Jun 15; 28(7):914-20.
    View in: PubMed
    Score: 0.012
  8. Pharmacologic treatment of anxiety disorders in Parkinson disease. Am J Geriatr Psychiatry. 2013 Jun; 21(6):520-8.
    View in: PubMed
    Score: 0.012
  9. Improving detection of psychiatric disturbances in Parkinson's disease: the role of informants. J Parkinsons Dis. 2013; 3(1):55-60.
    View in: PubMed
    Score: 0.012
  10. Application of depression rating scales in patients with Parkinson's disease with and without co-Occurring anxiety. J Parkinsons Dis. 2013; 3(4):603-8.
    View in: PubMed
    Score: 0.012
  11. Anxiety disorders, physical illnesses, and health care utilization in older male veterans with Parkinson disease and comorbid depression. J Geriatr Psychiatry Neurol. 2012 Dec; 25(4):233-9.
    View in: PubMed
    Score: 0.011
  12. Prevalence of psychotic symptoms in a community-based Parkinson disease sample. Am J Geriatr Psychiatry. 2012 Feb; 20(2):123-32.
    View in: PubMed
    Score: 0.011
  13. Anxiety and self-perceived health status in Parkinson's disease. Parkinsonism Relat Disord. 2011 May; 17(4):249-54.
    View in: PubMed
    Score: 0.010
  14. Familial aggregation of panic disturbances in Parkinson's disease. J Neuropsychiatry Clin Neurosci. 2011; 23(4):417-24.
    View in: PubMed
    Score: 0.010
  15. Detection of impulse control disorders in Parkinson disease patients. Neurologist. 2010 Nov; 16(6):406-7.
    View in: PubMed
    Score: 0.010
  16. Prevalence of anxiety disorders and anxiety subtypes in patients with Parkinson's disease. Mov Disord. 2009 Jul 15; 24(9):1333-8.
    View in: PubMed
    Score: 0.009
  17. Validity of the Cornell scale for depression in dementia in Parkinson's disease with and without cognitive impairment. Mov Disord. 2009 Feb 15; 24(3):433-7.
    View in: PubMed
    Score: 0.009
  18. Atomoxetine for the treatment of executive dysfunction in Parkinson's disease: a pilot open-label study. Mov Disord. 2009 Jan 30; 24(2):277-82.
    View in: PubMed
    Score: 0.009
  19. Non-dopaminergic treatment of cognitive impairment and dementia in Parkinson's disease: a review. J Neurol Sci. 2006 Oct 25; 248(1-2):104-14.
    View in: PubMed
    Score: 0.007
  20. Provisional diagnostic criteria for depression in Parkinson's disease: report of an NINDS/NIMH Work Group. Mov Disord. 2006 Feb; 21(2):148-58.
    View in: PubMed
    Score: 0.007
  21. Pilot screening for prodromal Parkinson's disease in post-9/11 Veterans with probable rapid eye movement sleep behavior disorder. Parkinsonism Relat Disord. 2025 Mar; 132:107309.
    View in: PubMed
    Score: 0.007
  22. Randomized placebo-controlled trial of donepezil in cognitive impairment in Parkinson's disease. Int J Geriatr Psychiatry. 2004 Jan; 19(1):1-8.
    View in: PubMed
    Score: 0.006
  23. Hippocampal volume deficits in alcoholic Korsakoff's syndrome. Neurology. 2003 Dec 23; 61(12):1716-9.
    View in: PubMed
    Score: 0.006
  24. Neuropsychiatric aspects of Parkinson's disease: recent advances. Curr Psychiatry Rep. 2003 May; 5(1):68-76.
    View in: PubMed
    Score: 0.006
  25. Ten most commonly asked questions about the psychiatric aspects of Parkinson's disease. Neurologist. 2003 Jan; 9(1):50-6.
    View in: PubMed
    Score: 0.006
  26. Psychiatric complications in patients with epilepsy: a review. Epilepsy Res. 2002 Mar; 49(1):11-33.
    View in: PubMed
    Score: 0.005
  27. Non-motor phenotypic subgroups in adult-onset idiopathic, isolated, focal cervical dystonia. Brain Behav. 2021 08; 11(8):e2292.
    View in: PubMed
    Score: 0.005
  28. Dystonia and Tremor: A Cross-Sectional Study of the Dystonia Coalition Cohort. Neurology. 2021 01 26; 96(4):e563-e574.
    View in: PubMed
    Score: 0.005
  29. Accuracy of the PHQ-2 Alone and in Combination With the PHQ-9 for Screening to Detect Major Depression: Systematic Review and Meta-analysis. JAMA. 2020 06 09; 323(22):2290-2300.
    View in: PubMed
    Score: 0.005
  30. Post-Traumatic Stress Disorder is Associated with further Increased Parkinson's Disease Risk in Veterans with Traumatic Brain Injury. Ann Neurol. 2020 07; 88(1):33-41.
    View in: PubMed
    Score: 0.005
  31. Patient Health Questionnaire-9 scores do not accurately estimate depression prevalence: individual participant data meta-analysis. J Clin Epidemiol. 2020 06; 122:115-128.e1.
    View in: PubMed
    Score: 0.005
  32. Clinical Correlates of Dream Enactment Behaviors in Previously Deployed OEF/OIF/OND Veterans: An Exploratory Analysis. J Neuropsychiatry Clin Neurosci. 2020; 32(2):147-153.
    View in: PubMed
    Score: 0.005
  33. Integration and Extension of Specialty Mental Healthcare Services to Community Practice in Parkinson Disease. Am J Geriatr Psychiatry. 2019 07; 27(7):712-719.
    View in: PubMed
    Score: 0.004
  34. Probability of major depression diagnostic classification using semi-structured versus fully structured diagnostic interviews. Br J Psychiatry. 2018 06; 212(6):377-385.
    View in: PubMed
    Score: 0.004
  35. Cervical dystonia and substance abuse. J Neurol. 2018 Apr; 265(4):970-975.
    View in: PubMed
    Score: 0.004
  36. Perceived Treatment Status of Fluctuations in Parkinson Disease Impacts Suicidality. Am J Geriatr Psychiatry. 2018 06; 26(6):700-710.
    View in: PubMed
    Score: 0.004
  37. Psychiatric associations of adult-onset focal dystonia phenotypes. J Neurol Neurosurg Psychiatry. 2017 07; 88(7):595-602.
    View in: PubMed
    Score: 0.004
  38. Active Mental Illnesses Adversely Affect Surgical Outcomes. Am Surg. 2016 Dec 01; 82(12):1238-1243.
    View in: PubMed
    Score: 0.004
  39. Factors Associated With Veterans' Access to Permanent Supportive Housing. Psychiatr Serv. 2016 08 01; 67(8):870-7.
    View in: PubMed
    Score: 0.004
  40. Modeling anxiety in Parkinson's disease. Mov Disord. 2016 Mar; 31(3):310-6.
    View in: PubMed
    Score: 0.004
  41. The longitudinal impact of depression on disability in Parkinson disease. Int J Geriatr Psychiatry. 2016 May; 31(5):458-65.
    View in: PubMed
    Score: 0.003
  42. Influence of schizophrenia diagnosis on providers' practice decisions. J Clin Psychiatry. 2015 Aug; 76(8):1068-74; quiz 1074.
    View in: PubMed
    Score: 0.003
  43. A Pilot Study of a Cognitive-Behavioral Treatment for Anxiety and Depression in Patients With Parkinson Disease. J Geriatr Psychiatry Neurol. 2015 Sep; 28(3):210-7.
    View in: PubMed
    Score: 0.003
  44. Apathy in Neurodegenerative Diseases: Recommendations on the Design of Clinical Trials. J Geriatr Psychiatry Neurol. 2015 Sep; 28(3):159-73.
    View in: PubMed
    Score: 0.003
  45. Mental health diagnoses and health care utilization in persons with dementia, Parkinson's disease, and stroke. J Neuropsychiatry Clin Neurosci. 2015; 27(2):e117-21.
    View in: PubMed
    Score: 0.003
  46. Alleviating manoeuvres (sensory tricks) in cervical dystonia. J Neurol Neurosurg Psychiatry. 2014 Aug; 85(8):882-4.
    View in: PubMed
    Score: 0.003
  47. Cognitive and motor function in long-duration PARKIN-associated Parkinson disease. JAMA Neurol. 2014 Jan; 71(1):62-7.
    View in: PubMed
    Score: 0.003
  48. Anxiety has specific syndromal profiles in Parkinson disease: a data-driven approach. Am J Geriatr Psychiatry. 2014 Dec; 22(12):1410-7.
    View in: PubMed
    Score: 0.003
  49. Modeling depression in Parkinson disease: disease-specific and nonspecific risk factors. Neurology. 2013 Sep 17; 81(12):1036-43.
    View in: PubMed
    Score: 0.003
  50. Rasch analysis of anxiety scales in Parkinson's disease. J Psychosom Res. 2013 May; 74(5):414-9.
    View in: PubMed
    Score: 0.003
  51. Cognitive behavioral therapy for depression and anxiety in Parkinson's disease: a clinical review. J Parkinsons Dis. 2012; 2(2):135-51.
    View in: PubMed
    Score: 0.003
  52. Gaps in treatment for anxiety in Parkinson disease. Am J Geriatr Psychiatry. 2011 Oct; 19(10):907-8.
    View in: PubMed
    Score: 0.003
  53. Ocular motor and sensory function in Parkinson's disease. Ophthalmology. 2012 Jan; 119(1):178-82.
    View in: PubMed
    Score: 0.003
  54. Anxiety rating scales in Parkinson's disease: a validation study of the Hamilton anxiety rating scale, the Beck anxiety inventory, and the hospital anxiety and depression scale. Mov Disord. 2011 Feb 15; 26(3):407-15.
    View in: PubMed
    Score: 0.003
  55. Symptomatology and markers of anxiety disorders in Parkinson's disease: a cross-sectional study. Mov Disord. 2011 Feb 15; 26(3):484-92.
    View in: PubMed
    Score: 0.003
  56. Neuropsychological Profile of Parkin Mutation Carriers with and without Parkinson Disease: The CORE-PD Study. J Int Neuropsychol Soc. 2011 Jan; 17(1):91-100.
    View in: PubMed
    Score: 0.002
  57. A recommended scale for cognitive screening in clinical trials of Parkinson's disease. Mov Disord. 2010 Nov 15; 25(15):2501-7.
    View in: PubMed
    Score: 0.002
  58. Frequency of known mutations in early-onset Parkinson disease: implication for genetic counseling: the consortium on risk for early onset Parkinson disease study. Arch Neurol. 2010 Sep; 67(9):1116-22.
    View in: PubMed
    Score: 0.002
  59. Co-existence of Parkinson's disease and progressive supranuclear palsy: case report and a review of the literature. Neurol Sci. 2011 Feb; 32(1):159-63.
    View in: PubMed
    Score: 0.002
  60. Piloting the NPF data-driven quality improvement initiative. Parkinsonism Relat Disord. 2010 Sep; 16(8):517-21.
    View in: PubMed
    Score: 0.002
  61. Predictors of parkin mutations in early-onset Parkinson disease: the consortium on risk for early-onset Parkinson disease study. Arch Neurol. 2010 Jun; 67(6):731-8.
    View in: PubMed
    Score: 0.002
  62. Fatigue rating scales critique and recommendations by the Movement Disorders Society task force on rating scales for Parkinson's disease. Mov Disord. 2010 May 15; 25(7):805-22.
    View in: PubMed
    Score: 0.002
  63. Self-report of cognitive impairment and mini-mental state examination performance in PRKN, LRRK2, and GBA carriers with early onset Parkinson's disease. J Clin Exp Neuropsychol. 2010 Aug; 32(7):775-9.
    View in: PubMed
    Score: 0.002
  64. Motor phenotype of LRRK2 G2019S carriers in early-onset Parkinson disease. Arch Neurol. 2009 Dec; 66(12):1517-22.
    View in: PubMed
    Score: 0.002
  65. Neuropsychiatric symptoms in Parkinson's disease. Mov Disord. 2009 Nov 15; 24(15):2175-86.
    View in: PubMed
    Score: 0.002
  66. The course of depressive symptoms in early Parkinson's disease. Mov Disord. 2009 Jul 15; 24(9):1306-11.
    View in: PubMed
    Score: 0.002
  67. Apathy and anhedonia rating scales in Parkinson's disease: critique and recommendations. Mov Disord. 2008 Oct 30; 23(14):2004-14.
    View in: PubMed
    Score: 0.002
  68. Anxiety rating scales in Parkinson's disease: critique and recommendations. Mov Disord. 2008 Oct 30; 23(14):2015-25.
    View in: PubMed
    Score: 0.002
  69. Scales to assess psychosis in Parkinson's disease: Critique and recommendations. Mov Disord. 2008 Mar 15; 23(4):484-500.
    View in: PubMed
    Score: 0.002
  70. Morphometry of the human substantia nigra in ageing and Parkinson's disease. Acta Neuropathol. 2008 Apr; 115(4):461-70.
    View in: PubMed
    Score: 0.002
  71. Diagnostic criteria for psychosis in Parkinson's disease: report of an NINDS, NIMH work group. Mov Disord. 2007 Jun 15; 22(8):1061-8.
    View in: PubMed
    Score: 0.002
  72. Fatigue in Parkinson's disease: a review. Mov Disord. 2007 Feb 15; 22(3):297-308.
    View in: PubMed
    Score: 0.002
  73. Alpha-synuclein and Parkinson's disease: implications from the screening of more than 1,900 patients. Mov Disord. 2005 Sep; 20(9):1191-4.
    View in: PubMed
    Score: 0.002
  74. Aggregation promoting C-terminal truncation of alpha-synuclein is a normal cellular process and is enhanced by the familial Parkinson's disease-linked mutations. Proc Natl Acad Sci U S A. 2005 Feb 08; 102(6):2162-7.
    View in: PubMed
    Score: 0.002
  75. Abeta deposition is associated with enhanced cortical alpha-synuclein lesions in Lewy body diseases. Neurobiol Aging. 2005 Aug-Sep; 26(8):1183-92.
    View in: PubMed
    Score: 0.002
  76. S-nitrosylation of parkin regulates ubiquitination and compromises parkin's protective function. Science. 2004 May 28; 304(5675):1328-31.
    View in: PubMed
    Score: 0.002
  77. Psychopathology in patients with degenerative cerebellar diseases: a comparison to Huntington's disease. Am J Psychiatry. 2002 Aug; 159(8):1306-14.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.